Loading Complete
Ruby Meredith

Ruby Meredith, MD, PhD

Radiation Oncology

Accepting New Patients

Highlights

Age Groups Seen

  • Adults
  • Geriatrics

Languages

  • English

About Ruby Meredith

Biography

She served on the Advisory Panel for the National Biotracer Facility Project as well as multiple other radionuclide related councils, and pharmaceutical industry consultant. These include >15 years on the Medical Internal Radiation Dosimetry committee of the Society of Nuclear Medicine (SNMMI). Her basic science background has facilitated development/conduct of multiple clinical trials. She has experience in the conduct of 50 clinical trials for targeted radionuclide therapy, including serving as a Principal Investigator for a Phase I Trial of Intraperitoneal Pb-212-TCMC-trastuzumab for HER-2 expressing malignancy. More details of her record are at http://www.uab.edu/medicine/radonc

Faculty Appointment

Professor Emeritus

Research Interests

Radiobiology, dosimetry and clinical aspects of targeted radiopharmaceutical therapy; hematologic, breast and ovarian cancer

Awards & Recognition

•1978 Outstanding Contribution in Health Research. Health Research and Services Foundation, United Way of Pittsburgh.
•1996 Circle of Excellence Award for Compassion
•2001 Selected for Inclusion in Best Doctors Listings, maintained through 2019.
see http://www.uab.edu/medicine/radonc for complete list

Memberships

American Society of Therapeutic Radiology and Oncology
American College of Radiation Oncology
American Association for Cancer Research
Society of Nuclear Medicine and Molecular Imaging
UAB Institutional Review Board for Human Use
see http://www.uab.edu/medicine/radonc for complete list

Expertise

Education

  • Residency: Medical College of Virginia Hospital, 1987
  • Internship: Medical College of Virginia Hospital, 1984
  • Medical School: Ohio State University College of Medicine, 1983

Board Certifications

  • Radiation Oncology: American Board of Radiology, 1987